Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19270239&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Vascular and other tissue calcification in peritoneal dialysis patients Wang AYPerit Dial Int 2009[Feb]; 29 Suppl 2 (ä): S9-S14Cardiovascular disease is the leading cause of mortality in patients with end-stage renal disease (ESRD) and is attributed to a combination of traditional and non-traditional cardiovascular risk factors. In recent years, there has also been an increasing recognition of a very high prevalence of cardiovascular calcification in the ESRD population, including in patients receiving long-term peritoneal dialysis (PD). Numerous observational cohort studies have demonstrated the prognostic importance of cardiovascular calcifications in these patients. The mechanisms are not completely understood, but are likely multifactorial. The present article reviews the prevalence, clinical course, prognostic significance, and some contributing factors for vascular and valvular calcification in ESRD patients, including patients receiving PD therapy.|1-Carboxyglutamic Acid[MESH]|Blood Proteins/metabolism[MESH]|Blood Vessels/*pathology[MESH]|C-Reactive Protein/metabolism[MESH]|Calcinosis/blood/epidemiology/*etiology[MESH]|Calcium-Binding Proteins/blood[MESH]|Extracellular Matrix Proteins/blood[MESH]|Heart Valve Diseases/blood/epidemiology/etiology[MESH]|Heart Valves/pathology[MESH]|Humans[MESH]|Kidney Failure, Chronic/*therapy[MESH]|Matrix Gla Protein[MESH]|Osteoprotegerin/blood[MESH]|Peritoneal Dialysis/*adverse effects[MESH]|Prevalence[MESH]|Prognosis[MESH]|Vascular Diseases/blood/epidemiology/*etiology[MESH]|alpha-2-HS-Glycoprotein[MESH] |